Evgenia Karpova

Ms. Evgenia Karpova

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
ARAnna Rubekina
Anna Rubekina
PKPolina Kamzeeva
Polina Kamzeeva
VAVera A. Alferova
Vera A. Alferova
SEShustova Elena
Shustova Elena
EKEkaterina Kolpakova
Ekaterina Kolpakova
AAAndrey V. Aralov
Andrey V. Aralov
Rose Bengal (RB) is an anionic xanthene dye with multiple useful biological features, including photosensitization properties. RB was studied extensively as a photosensitizer, mostly for antibacterial and antitumor photodynamic therapy (PDT). The application of RB to virus inactivation is rather understudied, and no RB derivatives have been developed as antivirals. In this work, we used a synthetic approach based on a successful design of photosensitizing antivirals to produce RB derivatives for virus photoinactivation. A series of n-alkyl-substituted RB derivatives was synthesized and evaluated as antiviral photosensitizers. The compounds exhibited similar 1O2 generation rate and efficiency, but drastically different activities against SARS-CoV-2, CHIKV, and HIV; with comparable cytotoxicity for different cell lines. Submicromolar-to-subnanomolar activities and high selectivity indices were detected for compounds with C4-6 alkyl (SARS-CoV-2) and C6-8 alkyl (CHIKV) chains. Spectrophotometric assessment demonstrates low aqueous solubility for C8-10 congeners and a significant aggregation tendency for the C12 derivative, possibly influencing its antiviral efficacy. Initial evaluation of the synthesized compounds makes them promising for further study as viral inactivators for vaccine preparations.

11 July 2023 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
OTOlga V. Tsvirkun
Olga V. Tsvirkun
NTNina T. Tikhonova
Nina T. Tikhonova
NTNatalya V. Turaeva
Natalya V. Turaeva
FTFarida Kh. Tishkova
Farida Kh. Tishkova
MRMurodali M. Ruziev
Murodali M. Ruziev
LKLiubov Kozlovskaya
Liubov Kozlovskaya
Relevance. To achieve the goals of measles and rubella elimination and poliomyelitis eradication programs, immunization coverage of at least 95% of the target population is required. Objective data on the state of specific herd immunity are provided only by the results of serosurveys. In the Republic of Tajikistan, such monitoring is not carried out regularly. Therefore, the purpose of the study was to assess the actual state of the specific herd immunity to measles, rubella, and poliomyelitis viruses. Materials and methods. The blood sera of 563 children and adults collected in 7 cities and 13 districts of Tajikistan in 2020 were investigated. The level of antibodies (ABs) to measles and rubella viruses was determined using enzyme immunoassay. Test systems VectoKor-IgG (VECTOR-BEST, Russia) and Ecolab, Russia were used to determine ABs to measles and rubella virus, respectively. Neutralizing antibodies (nABs) to the 3 types of poliovirus (PV) were determined in 359 sera using a neutralization reaction with Sabin strains of types 1, 2, 3. Results. The conducted serosurvey showed the level of the specific herd immunity to rubella to be 87.9% in total population, including 86.2% in children, 93.1% in adolescents, and 93.5% and adults, that is sufficient to prevent transmission of the rubella virus. The proportion of individuals seropositive to measles was 54.5%, which is not enough to prevent sustained secondary transmission of infection and the resumption of circulation of the endemic strain of measles virus. The children under 15 years of age should be considered a population at risk of the infection, since children accounted for 38% among seronegative individuals. In general, less than 95% of the examined patients had nABs to PV: 94.4% to PV1, 86.1% to PV2, 83.6% to PV3; 3.3% did not have antibodies to all three types of PV. The level of herd immunity varied in the examined groups depending on the vaccination schedule and the composition of the poliovirus vaccines used: nABs to PV2 had 59.6% of children born during the period when vaccines containing PV2 were not used, and 85.7% of children born after the introduction of trivalent IPV. Deficiency in immunity to PV2 was the cause of a polio outbreak in 2021 caused by circulating vaccine-derived PV type 2. Conclusion. A high level of humoral immunity to the rubella virus was determined. Shortcomings of routine immunization against measles and polio associated with insufficient coverage and lack of IPV have been identified. Conducting regular serological monitoring in the Republic of Tajikistan is advisable to obtain objective information about the level of herd immunity, identify vulnerable groups of the population, and plan additional immunization activities.

25 November 2025 in Journal of Medical Virology
Verified
Journal Article
Closed access
ASArmen K. Shakaryan
Armen K. Shakaryan
YMYulia M. Mikhailova
Yulia M. Mikhailova
ACAlina V. Chirova
Alina V. Chirova
ECEvgeniya A. Cherepanova
Evgeniya A. Cherepanova
OBOlga Y. Baikova
Olga Y. Baikova
OIOlga Ivanova
Olga Ivanova

23 May 2025 in Viruses
Verified
Journal Article
Open access
PDF file
OIOlga Ivanova
Olga Ivanova
YMYulia M. Mikhailova
Yulia M. Mikhailova
NMNadezhda S. Morozova
Nadezhda S. Morozova
ACAlina V. Chirova
Alina V. Chirova
ECEvgeniya A. Cherepanova
Evgeniya A. Cherepanova
LKLiubov Kozlovskaya
Liubov Kozlovskaya
The detection of “silent” poliovirus (PV) circulation among clinically healthy populations is an important component of supplementary surveillance for poliomyelitis. Migrants from countries or regions where polio is endemic, affected by outbreaks, or at risk may contribute to the introduction of PVs of epidemic significance: wild poliovirus type 1, vaccine-derived polioviruses (VDPVs), or poliovirus type 2 into polio-free countries. Migrant children, refugees under 5 years of age, are considered a “risk group” in Russia and are subject to testing for PVs. During 2014–2023, guided by the algorithm of virological and molecular investigation of acute flaccid paralysis cases recommended by the WHO, 51,548 migrant children, arriving from 40 countries, were examined. Among 4% of children excreting various cytopathogenic viruses, polio excretors accounted for 20.8%. Among the PVs, PV3 was predominant (41.7%), and PV types 2, 1, and a mixture of PVs accounted for, respectively, 28.2%, 18.8%, and 11.3%. All isolates of PVs 1 and 3 were identified as Sabin-like. The detection of five children excreting epidemically significant PV2 (four VDPV2 and one Sabin-like) required an assessment of the risk of dissemination and additional immunization activities. Among 580 identified isolates of NPEV, the most abundant was the E. betacoxsakie species at 73.8% (CVB1–6, E11, E6, E13, E7). Information on NPEVs expands our knowledge of the spectrum of NPEVs circulating among healthy children worldwide, but its prognostic significance is still unclear. The detection of PVs in children from the “risk group” allows targeted anti-epidemic measures and is a significant advantage of this type of supplementary surveillance for polio.

8 October 2026 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
EYElizaveta V. Yakovchuk
Elizaveta V. Yakovchuk
ESElena Yu. Shustova
Elena Yu. Shustova
LGLiudmila N. Galitzina
Liudmila N. Galitzina
EKEvgenia Karpova
Evgenia Karpova
OBOlga Yu. Baykova
Olga Yu. Baykova
LKLiubov Kozlovskaya
Liubov Kozlovskaya